Hospital Acquired Infection Control Market, By Type (Equipment, Services, and Consumables), By End Use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
REPORT HIGHLIGHT
Hospital Acquired Infection Control Market size was valued at USD 21,345.98 Million in 2024, expanding at a CAGR of 6.80% from 2024 to 2032.
Hospital-Acquired Infection (HAI) Control refers to the systematic implementation of strategies within healthcare settings to prevent, monitor, and manage infections that patients contract during their hospital stay. These infections typically occur 48 hours or more after admission and were neither present nor incubating at the time of entry. Effective HAI control relies on a multi-faceted approach that includes strict hygiene practices, sterilization of medical instruments, proper use of personal protective equipment (PPE), antimicrobial stewardship, and ongoing staff training. Surveillance systems play a vital role in identifying infection trends and responding promptly to outbreaks.
Common types of HAIs include bloodstream infections, urinary tract infections, pneumonia, and surgical site infections. The primary goals of HAI control are to safeguard patients and healthcare personnel, reduce complications, lower healthcare costs, and improve overall patient outcomes. Success in infection control depends on continuous education, adherence to evidence-based guidelines—such as those provided by the CDC and WHO—and strong institutional commitment to maintaining a safe and sterile clinical environment.
Hospital Acquired Infection Control Market- Market Dynamics
Increasing Awareness of Hospital-Acquired Infections (HAIs)
Increasing awareness of the risks and consequences associated with hospital-acquired infections (HAIs) is a major driver of the HAI control market. Healthcare professionals, administrators, and patients are becoming more informed about the serious implications of HAIs, including prolonged hospital stays, elevated healthcare costs, and increased mortality rates. This heightened awareness has led healthcare facilities to place greater emphasis on infection prevention and invest in advanced control technologies. Global health authorities such as the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC) have issued stringent guidelines, reinforcing the critical need for effective HAI surveillance and prevention strategies. In response, hospitals are implementing comprehensive infection control protocols, utilizing antimicrobial surfaces, sterilization equipment, and digital monitoring systems to minimize infection risks.
Public health campaigns and widespread media coverage have also played a key role in educating the general public, leading to higher patient expectations regarding hospital safety standards. As a result, the demand for infection control solutions is growing across both developed and emerging markets, as healthcare systems strive to meet evolving safety requirements and improve patient outcomes. According to a systematic review and meta-analysis published in PubMed, the global rate of hospital-acquired infections is 0.14%, with an annual increase of 0.06% . The World Health Organization reports that in acute-care hospitals, 7 out of every 100 patients in high-income countries and 15 out of every 100 patients in low- and middle-income countries acquire at least one healthcare-associated infection during their stay . These statistics underscore the urgent need for enhanced infection prevention and control measures worldwide.
Hospital Acquired Infection Control Market- Segmentation Analysis:
The global Hospital Acquired Infection Control market is divided into three categories: type, end use and region.
The Hospital Acquired Infection (HAI) Control market is segmented by type into Equipment, Services, and Consumables. Among these, Equipment is expected to dominate the market, primarily due to increasing investments in advanced disinfection technologies such as UV-C light systems, automated sterilization units, and high-efficiency particulate air (HEPA) filtration systems. These devices are critical in maintaining sterile environments, particularly in high-risk areas like intensive care units (ICUs) and operating rooms. Hospitals are focusing on long-term, infrastructure-based infection prevention strategies that align with international safety standards, leading to sustained demand for robust disinfection and sterilization equipment. In contrast, Services such as infection surveillance and compliance training, along with Consumables like disinfectants, gloves, and masks, remain essential for day-to-day infection prevention. However, the shift toward modernizing healthcare facilities and enhancing infection resilience has positioned equipment as the market leader. According to the Centers for Disease Control and Prevention (CDC), over $3 billion in federal funding was allocated in 2024 toward hospital infection control modernization, signaling strong governmental backing for equipment upgrades and advanced prevention systems.
The HAI Control market is also segmented by end-use into Hospitals and Intensive Care Units (ICUs), Ambulatory Surgical and Diagnostic Centres, and Others including long-term care facilities and clinics. Hospitals and ICUs are projected to lead the market due to the high concentration of critical patients, frequent use of invasive procedures, and extended durations of hospital stays, all of which heighten the risk of infection transmission. ICUs, in particular, care for immunocompromised patients and utilize complex medical equipment, making them especially vulnerable to HAIs. To combat these risks, healthcare providers invest significantly in infection control infrastructure, consumables, and professional services. Additionally, adherence to strict hygiene protocols and government-imposed regulations has driven widespread adoption of HAI control solutions in these settings. The World Health Organization (WHO) reported in 2024 that HAIs affect one in every ten hospitalized patients globally, reinforcing the urgency of comprehensive infection control measures, especially in high-risk hospital units. As such, hospitals and ICUs remain the dominant consumers of HAI control technologies and services.
Hospital Acquired Infection Control Market- Geographical Insights
The Hospital-Acquired Infection (HAI) Control market is geographically segmented across North America, Asia Pacific, Latin America, Europe, the Middle East, and Africa, with regional variations driven by healthcare infrastructure, regulatory frameworks, and infection prevalence.
North America holds a leading position in the global HAI Control market, primarily due to its advanced healthcare infrastructure, stringent regulatory policies, and high awareness of infection prevention. The United States dominates the region, with the Centers for Disease Control and Prevention (CDC) enforcing strict guidelines to mitigate the risk of HAIs. This has prompted hospitals and healthcare facilities to adopt comprehensive infection control measures, including the use of sterilization equipment, disinfectants, and personal protective equipment (PPE). High investments in automated sterilization technologies and environmental decontamination systems, such as UV disinfection and HEPA filtration units, further contribute to market growth. Canada also plays a key role, with federal and provincial health agencies promoting public health initiatives and implementing modern infection prevention practices across healthcare institutions.
Europe is another prominent region in the HAI Control market, driven by robust healthcare systems, a strong emphasis on patient safety, and supportive regulatory environments. The European Union has implemented health and safety directives that mandate rigorous infection control protocols, encouraging the adoption of advanced technologies in hospitals. Countries such as Germany, the United Kingdom, and France are at the forefront, investing in UV sterilization systems, antimicrobial surfaces, and advanced surveillance tools to minimize infection risks. The region benefits from well-established collaborations between public health authorities and private sector players, ensuring widespread adoption of effective infection prevention solutions. Europe\'s proactive stance on healthcare quality and safety continues to foster market expansion, making it a vital player in the global HAI control landscape.
Hospital Acquired Infection Control Market- Competitive Landscape:
The competitive dynamics of the Hospital-Acquired Infection (HAI) Control market are driven by a combination of established global players and emerging innovators that are introducing advanced technologies to improve infection prevention. Leading companies such as 3M, Belimed Inc., Getinge, and STERIS dominate the market by offering a broad portfolio of infection control solutions, including sterilization systems, disinfectants, and personal protective equipment (PPE). These firms emphasize stringent regulatory compliance, consistent product quality, and ongoing investment in research and development to stay ahead in a highly regulated and safety-critical industry. In response to growing demand for precision and efficiency, these market leaders are also integrating digital health solutions, such as automated surveillance systems and data analytics platforms, to support real-time infection tracking and enhanced hospital hygiene practices.
New entrants and niche players—such as W&H and Midmark Corporation—are gaining traction by launching innovative sterilization technologies and automation tools that streamline operations and improve safety. Sterigenics, another notable player, is focused on expanding its global sterilization capabilities through advanced gamma sterilization techniques, particularly for high-risk environments and medical equipment. This competitive environment is fueling rapid innovation, leading to improved hospital workflows, stronger infection prevention protocols, and better patient outcomes.
Recent Developments:
- September 2023: 3M launched the Clean-Coat Surface Protectant, a high-performance antimicrobial surface coating that eliminates up to 99.9% of bacteria and viruses on frequently touched hospital surfaces, aiming to reduce cross-contamination risks.
- October 2023: Getinge acquired Healthmark Industries Co., Inc., strengthening its footprint in the U.S. infection control market and expanding its range of instrument sterilization and regulatory compliance solutions.
- March 2024: W&H introduced the eLog system, a digital sterilization logbook that automatically records and stores sterilization cycles and routine tests, ensuring regulatory compliance and improving workflow efficiency.
- July 2024: Midmark Corporation launched its next-generation M11 and M9 steam sterilizers, featuring enhanced durability, improved processing speeds, and integrated documentation tools to boost productivity and compliance in instrument processing.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- 3M
- Belimed Inc.
- O&M Halyards
- Getinge
- ASP (Advanced Sterilization Products Services, Inc.)
- Sterigenics U.S., LLC - A Sotera Health Company
- MMM Group
- Midmark Corporation
- STERIS
- W&H
- Others
GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032
- Equipment
- Sterilization Equipment
- Heat Sterilization Equipment
- Low Temperature Sterilization
- Radiation Sterilization
- Disinfection Equipment
- Washer Disinfector
- Flusher Disinfector
- Endoscopic Reprocessor Systems
- Sterilization Equipment
- Services
- Consumables
- Disinfectants
- Sterilization Consumables
GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET, BY END USE - MARKET ANALYSIS, 2019 - 2032
- Hospitals and Intensive Care Units (ICUs)
- Ambulatory Surgical and Diagnostic Centres
- Others
GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Hospital Acquired Infection Control Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Hospital Acquired Infection Control Market Snippet by Type
2.1.2. Hospital Acquired Infection Control Market Snippet by End-Use
2.1.3. Hospital Acquired Infection Control Market Snippet by Country
2.1.4. Hospital Acquired Infection Control Market Snippet by Region
2.2. Competitive Insights
3. Hospital Acquired Infection Control Key Market Trends
3.1. Hospital Acquired Infection Control Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Hospital Acquired Infection Control Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Hospital Acquired Infection Control Market Opportunities
3.4. Hospital Acquired Infection Control Market Future Trends
4. Hospital Acquired Infection Control Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Hospital Acquired Infection Control Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Hospital Acquired Infection Control Market Landscape
6.1. Hospital Acquired Infection Control Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Hospital Acquired Infection Control Market – By Type
7.1. Overview
7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
7.1.2. Equipment
7.1.2.1. Sterilization Equipment
7.1.2.1.1. Heat Sterilization Equipment
7.1.2.1.2. Low Temperature Sterilization
7.1.2.1.3. Radiation Sterilization
7.1.2.2. Disinfection Equipment
7.1.2.2.1. Washer Disinfector
7.1.2.2.2. Flusher Disinfector
7.1.2.2.3. Endoscopic Reprocessor Systems
7.1.3. Services
7.1.4. Consumables
7.1.4.1. Disinfectants
7.1.4.2. Sterilization Consumables
8. Hospital Acquired Infection Control Market – By End-Use
8.1. Overview
8.1.1. Segment Share Analysis, By End-Use, 2023 & 2032 (%)
8.1.2. Hospitals and Intensive Care Units (ICUs)
8.1.3. Ambulatory Surgical and Diagnostic Centres
8.1.4. Others
9. Hospital Acquired Infection Control Market– By Geography
9.1. Introduction
9.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
9.2. North America
9.2.1. Overview
9.2.2. Hospital Acquired Infection Control Key Manufacturers in North America
9.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
9.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.2.5. North America Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
9.2.6. U.S.
9.2.6.1. Overview
9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.2.6.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.2.6.4. U.S. Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
9.2.7. Canada
9.2.7.1. Overview
9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.2.7.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.2.7.4. Canada Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
9.3. Europe
9.3.1. Overview
9.3.2. Hospital Acquired Infection Control Key Manufacturers in Europe
9.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
9.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.3.5. Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
9.3.6. Germany
9.3.6.1. Overview
9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.3.6.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.3.6.4. Germany Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
9.3.7. France
9.3.7.1. Overview
9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.3.7.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.3.7.4. France Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
9.3.8. Italy
9.3.8.1. Overview
9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.3.8.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.3.8.4. Italy Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
9.3.9. Spain
9.3.9.1. Overview
9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.3.9.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.3.9.4. United Kingdom Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
9.3.10. United Kingdom
9.3.10.1. Overview
9.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.3.10.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.3.10.4. United Kingdom Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
9.3.11. Russia
9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.3.11.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.3.11.3. Russia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
9.3.12. Netherlands
9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.3.12.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.3.12.3. Netherlands Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
9.3.13. Sweden
9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.3.13.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.3.13.3. Sweden Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
9.3.14. Poland
9.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.3.14.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.3.14.3. Poland Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
9.3.15. Rest of Europe
9.3.15.1. Overview
9.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.3.15.4. Rest of the Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
9.4. Asia Pacific (APAC)
9.4.1. Overview
9.4.2. Hospital Acquired Infection Control Key Manufacturers in Asia Pacific
9.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
9.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.4.5. Asia Pacific Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
9.4.6. India
9.4.6.1. Overview
9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.4.6.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.4.6.4. India Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
9.4.7. China
9.4.7.1. Overview
9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.4.7.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.4.7.4. China Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
9.4.8. South Korea
9.4.8.1. Overview
9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.4.8.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.4.8.4. South Korea Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
9.4.9. Japan
9.4.9.1. Overview
9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.4.9.4. Japan Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
9.4.10. Australia
9.4.10.1. Overview
9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.4.10.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.4.10.4. Australia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
9.4.11. Thailand
9.4.11.1. Overview
9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.4.11.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.4.11.4. Thailand Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
9.4.12. Indonesia
9.4.12.1. Overview
9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.4.12.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.4.12.4. Indonesia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
9.4.13. Philippines
9.4.13.1. Overview
9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.4.13.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.4.13.4. Philippines Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
9.4.14. Rest of APAC
9.4.14.1. Overview
9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.4.14.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.4.14.4. Rest of APAC Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
9.5. Latin America
9.5.1. Overview
9.5.2. Hospital Acquired Infection Control Key Manufacturers in Latin America
9.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
9.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.5.5. Latin America Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
9.5.6. Brazil
9.5.6.1. Overview
9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.5.6.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.5.6.4. Brazil Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
9.5.7. Mexico
9.5.7.1. Overview
9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.5.7.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.5.7.4. Mexico Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
9.5.8. Argentina
9.5.8.1. Overview
9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.5.8.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.5.8.4. Argentina Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
9.5.9. Colombia
9.5.9.1. Overview
9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.5.9.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.5.9.4. Colombia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
9.5.10. Rest of LATAM
9.5.10.1. Overview
9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.5.10.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.5.10.4. Rest of LATAM Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
9.6. Middle East and Africa
9.6.1. Overview
9.6.2. Hospital Acquired Infection Control Key Manufacturers in Middle East and Africa
9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
9.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.6.5. Middle East and Africa Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
9.6.6. Saudi Arabia
9.6.6.1. Overview
9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.6.6.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.6.6.4. Saudi Arabia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
9.6.7. United Arab Emirates
9.6.7.1. Overview
9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.6.7.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.6.7.4. United Arab Emirates Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
9.6.8. Israel
9.6.8.1. Overview
9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.6.8.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.6.8.4. Israel Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
9.6.9. Turkey
9.6.9.1. Overview
9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.6.9.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.6.9.4. Turkey Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
9.6.10. Algeria
9.6.10.1. Overview
9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.6.10.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.6.10.4. Algeria Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
9.6.11. Egypt
9.6.11.1. Overview
9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.6.11.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.6.11.4. Egypt Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
9.6.12. Rest of MEA
9.6.12.1. Overview
9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.6.12.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.6.12.4. Rest of MEA Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10. Key Vendor Analysis- Hospital Acquired Infection Control Industry
10.1. Competitive Dashboard
10.2. Company Profiles
10.2.1. 3M
10.2.2. Belimed Inc.
10.2.3. O&M Halyards
10.2.4. Getinge
10.2.5. ASP (Advanced Sterilization Products Services, Inc.)
10.2.6. Sterigenics U.S., LLC - A Sotera Health Company
10.2.7. MMM Group
10.2.8. Midmark Corporation
10.2.9. STERIS
10.2.10. W&H
10.2.11. Others
11. 360 Degree Analyst View
12. Appendix
12.1. Research Methodology
12.2. References
12.3. Abbreviations
12.4. Disclaimer
12.5. Contact Us
